“Real-world Effectiveness of Tralokinumab in Adults with Atopic Dermatitis: Interim Data on Improvements in Patients with Head and Neck Atopic Dermatitis after up to 9 Months of Treatment in the TRACE Study”, J of Skin, vol. 9, no. 2, p. s574, Mar. 2025, doi: 10.25251/skin.10.supp.574.